Fig. 2From: Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based surveyPerception of background risk and for drugs with no or minor excess risk. Perception of teratogenic risk by GPs (grey) and OB/GYN (white) of drugs known to be safe during pregnancy and the overall background incidence. Boxplot with medians and 50 % interpercentil ranges with whiskers from the 10th to 90th percentiles. Statistically significant p- values are indicatedBack to article page